<DOC>
	<DOCNO>NCT02415777</DOCNO>
	<brief_summary>A multi-center , randomize , double-blind , placebo-controlled trial evaluate efficacy safety 'URSA SOFT CAP . ( UDCA-003 ) ' fatigue patient liver dysfunction</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety 'URSA SOFT CAP . ( UDCA-003 ) ' Fatigue Patients With Liver Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>CIS great equal 76 , HADS le equal 10 ALT great upper limit normal OR fatty liver US Subjects diseases cause fatigue Subjects take medication cause fatigue</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>